|
|
Effects of Different Analgesic Regimens on Postoperative Analgesia and Immune Function in Patients with Cancer |
HUO Miao, ZHANG Qian, et al |
Shaanxi People's Hospital, Shaanxi Xi'an 710000, China |
|
|
Abstract Objective: To study the effects of different analgesic regimens on postoperative analgesia and immune function in patients with cancer. Methods: 120 cases of tumor patients admitted to our hospital for surgery from January 2015 to January 2018 were included in the study and were divided into the following four groups according to simple random grouping method, including group A (sufentanil + dezocine + ondansetron, n=30), group B (suffentanil + NSAIDS + ondansetron, n=30), group C (dezocine+ NSAIDS + ondansetron, n=30) and group D (sufentanil + dezocine + NSAIDS + ondansetron, n=30). The postoperative analgesic effects and body immune function were counted among the four groups. Results: At each time point after operation, the VAS scores in resting and coughing status in group D were significantly lower than those in the other three groups (P<0.05). The frequency of intravenous analgesia (PCIA) compression in group D at each time point was less than that in the other three groups (P<0.05). There were no interactions between CD3+, CD4+, CD8+ and CD4+/CD8+ at each time point among the four groups, and there were interactions in the number of NK cells among the four groups at each time point (P<0.05), and the number of NK cells in groups B and C after operation was decreased, and there was significant difference at different time points within-groups (P<0.05), and there was no significant difference between groups B and group D at each time point (P>0.05). There was a significant difference in the adverse reactions rate among the four groups after operation (P<0.05), and there were significant differences in adverse reactions between group A and group B, between group B and group C and between group B and group D (P<0.05). Conclusions: Sufentanil + dezocine + non-steroidal anti-inflammatory drugs (NSAIDS) + ondansetron can effectively control postoperative pain in patients with cancer, reduce the immunosuppression caused by postoperative pain, and reduce the amount of anesthetic drugs, and it has high safety and is worthy of clinical promotion.
|
|
|
|
|
[1] 何丹,刘翼,吴振华,等.胸腹腔镜与传统开放手术治疗食管癌的围手术期疗效对比[J].中国癌症杂志,2016,26(11):932~938. [2] 赵晶,汪艳,许涛,等.静脉自控镇痛与硬膜外镇痛对膝关节置换术后患者胃肠动力的影响[J].山东医药,2016,56(2):45~46. [3] 洪彬源,刘洪珍,潘晓梅,等.多模式的镇痛方法对结肠癌根治术患者的免疫功能的影响[J].免疫学杂志,2016,32(4):351~355. [4] 梁燕冰,雷洪伊,徐世元.基因多态性对阿片类药物术后镇痛效果的影响[J].广东医学,2017,38(S1):288~291,294. [5] 刘思颖,孙兆楚,吕楠,等.硬膜外镇痛对开腹胰腺肿瘤手术患者术后恢复的影响[J].临床麻醉学杂志,2017,33(6):554~556. [6] 李九会,郭荣,李寿,等.舒芬太尼联合地佐辛用于剖宫产术后镇痛的疗效及对患者血清泌乳素水平的影响[J].现代生物医学进展,2016,16(25):4873~4875,4908. [7] 吕勇,丁惠,韩冬良,等.地佐辛复合舒芬太尼用于恶性肿瘤根治术后静脉自控镇痛的临床研究[J].中华肿瘤防治杂志,2016,23(S2):295~296. [8] 蒋奕红,谢景远,熊威威,等.血浆谷氨酸与γ-氨基丁酸水平对麻醉后幼儿早期认知功能障碍的相关性研究[J].中国临床药理学杂志,2016,32(6):523~525. |
|
|
|